Physician profile
Carly L Isaacs
NPI 1407502164
$1,718.10
in general payments reported to CMS, 2019-2025
8 companies · $892 in 2025
The $892 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $161 · 2024: $665 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,718.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $536.90 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $452.43 | 2023-2024 | Invega Trinza, Invega Sustenna, Invega |
| Otsuka America Pharmaceutical, INC. | $237.53 | 2024-2025 | Abilify Asimtufii, Abilify Maintena |
| Alkermes, INC. | $226.03 | 2025 | Aristada, Lybalvi |
| Gilead Sciences, INC. | $173.54 | 2024-2025 | |
| Lilly USA, LLC | $54.27 | 2025 | Mounjaro, Zepbound |
| Viiv Healthcare Company | $24.65 | 2024 | |
| Glaxosmithkline, LLC. | $12.75 | 2023 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carly Isaacs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.